INDIA

Baba Ramdev Releases Research Papers On ‘Evidence-Based’ COVID-19 Medicine Coronil

Mumbai: Yoga guru Ramdev on Friday released the first evidence-based drug for coronavirus by Patanjali. Union Health Minister Dr. Harshvardhan and Union Minister Nitin Gadkari were also present at the event. The drug for which the data has been released is Coronil.

Earlier last year, Patanjali claimed that its Ayurvedic drug ‘Coronil’ could cure coronavirus infection. A petition was later filed in a Delhi court directing the police to register an FIR against Ramdev, Patanjali Ayurved Ltd, Acharya Balakrishna and others.

Also Read: Uttarakhand Glacier Brust: One more Body Recovered, Toll Now 62

However, after confronting Flak, Patanjali’s coronil kit was acquired as an ‘immune booster’.

Ayurveda has Rs 30,000 Cr economy in India. As per official data, it used to see a growth of 15-20% every yr pre-COVID. Post-COVID, this growth rate has risen to 50-90%. It’s an indication that people have accepted it. There’s marked improvement in exports & FDI”, said the health minister

Ramdev also released a research paper containing all scientific protocols for testing coronil while launching the drug. He said nine of these research papers have been published in international journals, while fifteen others are in the pipeline.

Also Read: 500 People Booked For Flouting COVID-19 Norms At Birthday Party In Thane

He also said that the aim of this launch is to establish Yoga and Ayurveda as global solutions for diseases.

2.44 million people worldwide have died of coronovirus disease. Various vaccines have been approved by the regulatory bodies of the respective countries to prevent the disease for emergency use.

More than 200 vaccine candidates are expected under development worldwide. Meanwhile, drugs used to treat other infections and diseases have been reconstituted and tested for COVID-19 treatment, but no specific drug or drug has been approved globally.

Follow us on TwitterInstagram, and like us on Facebook for the latest updates and interesting stories.

Tags
Show More

Comments

Close

Adblock Detected

Please consider supporting us by disabling your ad blocker